TD Cowen Sticks to Its Buy Rating for Krystal Biotech (KRYS)April 23, 2025TipRanks Bank of America Securities Sticks to Their Buy Rating for Krystal Biotech (KRYS)April 17, 2025TipRanks Krystal Biotech’s Jeune Aesthetics names Marc Forth as CEOApril 7, 2025TipRanks William Blair Keeps Their...
Krystal Biotech IncKRYS:NASDAQ RT Quote|Last NASDAQ LS, VOL From CTA|USD After Hours:Last |4:00 PM EDT 136.80UNCH(UNCH) Volume 18,479 Close 136.80-2.67(-1.91%) Volume 692,771 52 week range 133.22-219.34 Latest On Krystal Biotech Inc ...
美银证券维持Krystal Biotech(KRYS.US)买入评级,维持目标价200美元 美银证券分析师Alec Stranahan维持$Krystal Biotech(KRYS.US)$买入评级,维持目标价200美元。根据TipRanks数据显示,该分析师近一年总胜率为32.4%,总平均回报率为-15.0%。提示: TipRanks为独立第三方,提供金融分析师的分析数据,并计算分析师推荐的平均...
Use Futu NiuNiu to view Krystal Biotech (KRYS)'s stock price, real-time quotes, latest news, historical trend charts, financial information and quotes.
Krystal Biotech Inc stock (KRYS) in USD 1 KRYS = 137.17 USD 1 month 6 months 1 year 5 yearsKrystal Biotech Inc stock performance at a glance Check Krystal Biotech Inc’s past financial performance, like revenue or net income, plus the top level summary of its past and current market valu...
The Investor Relations website contains information about Krystal Biotech, Inc.'s business for stockholders, potential investors, and financial analysts.
基因疗法公司Krystal Biotech Inc. (NASDAQ: KRYS)宣布2024年第三季度实现盈利,每股收益显著增加,其主打产品VYJUVEK的收入大幅增长。在2024年11月1日的业绩电话会议上,公司概述了其成功的商业策略,包括高度关注患者和医生体验,这推动了需求和报销审批。Krystal Biotech还讨论了其临床管线的进展,并提供了在欧洲和日本扩...
Krystal Biotech announced positive initial clinical results from its KYANITE-1 study on inhaled KB707 for lung tumors, particularly showing monotherapy efficacy in advanced non-small cell lung cancer (NSCLC) patients. The study demonstrated a 27% objective response rate and a 73% disease control rat...
Earnings estimates and surprises for Krystal Biotech Inc (KRYS) are an important tool used to evaluate the company's overall strength and value of the stock.
KRYS - Krystal Biotech Inc. Chart, Quote and financial news from the leading provider and award-winning BigCharts.com.